甲状旁腺癌风险分层预后评分系统
Parathyroid carcinoma is a rare endocrine malignancy that lacks an established system for risk categorization. This study evaluated a prognostic scoring system for recurrence-free survival (RFS) of patients with parathyroid carcinoma.…
要点
- 年龄>65岁、血钙>15 mg/dL和血管侵犯是甲状旁腺癌RFS的独立不良因素。
- 基于上述3个变量构建的评分系统可将患者分为低危(0个变量)、中危(1个变量)和高危(2个变量)。
- 该评分系统或有助于指导辅助治疗的时机与选择,但尚需外部验证。
核心结论
- 基于血管侵犯、年龄和初始手术时血钙水平的预后评分系统可预测甲状旁腺癌的无复发生存率。
研究设计与样本
- 采用单因素和多因素Cox比例风险回归分析RFS,并基于多因素分析结果构建预后评分系统。
主要发现
- 中位随访4.6年,26例患者出现复发。
- 初始手术后1年、2年和10年的Kaplan-Meier RFS率分别为85%(95% CI 77%~95%)、67%(95% CI 55%~81%)和51%(95% CI 36%~72%)。
- 多因素分析显示年龄>65岁、血清钙>15 mg/dL和血管侵犯与RFS率呈负相关。
- 低危组(0个变量)2年RFS率为93%,中危组(1个变量)为72%,高危组(2个变量)为27%(p=0.001,log-rank检验;一致性指数0.70,95% CI 0.47~0.92)。
关键数值与推荐
- 预后评分系统包含3个不良变量:年龄>65岁、血清钙>15 mg/dL、血管侵犯。
- 风险分组:低危(0个变量)、中危(1个变量)、高危(2个变量)。
- 2年RFS率:低危93%、中危72%、高危27%(p=0.001)。
- 一致性指数0.70(95% CI 0.47~0.92)。
临床怎么用
- 对于甲状旁腺癌患者,初始手术时评估年龄、血钙和血管侵犯情况,可进行风险分层。
- 高危患者(2个变量)2年RFS率仅27%,可能需更密切随访并考虑辅助治疗。
- 该评分系统或有助于临床决策辅助治疗的时机和使用,但需多队列验证确认适用性。
局限性
- 需多队列综合验证以确认适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Parathyroid carcinoma is a rare endocrine malignancy that lacks an established system for risk categorization. This study evaluated a prognostic scoring system for recurrence-free survival (RFS) of patients with parathyroid carcinoma. Patients diagnosed and confirmed to have parathyroid carcinoma and who were treated between 1980 and 2016 at The University of Texas MD Anderson Cancer Center were studied retrospectively. Univariate and multivariate Cox proportional hazards regression analyses of RFS were conducted. A prognostic scoring system was created based on multivariate analysis. Sixty-eight patients were evaluated. After a median follow-up of 4.6 years, 26 patients experienced a recurrence. The Kaplan-Meier RFS rates were 85% at 1 year (95% CI 77% to 95%), 67% at 2 years (95% CI 55% to 81%), and 51% at 10 years (95% CI 36% to 72%) after initial operation. Multivariate analysis demonstrated that age older than 65 years, serum calcium level >15 mg/dL, and vascular invasion were negatively correlated with RFS rate. Combining these adverse variables into a prognostic scoring system, we stratified patients into 3 risk groups: low (0 variable; 2-year RFS rate, 93%), moderate (1 variable; 2-year RFS rate, 72%), and high (2 variables; 2-year RFS rate, 27%) (p = 0.001 [log-rank test]; concordance index, 0.70; 95% CI 0.47 to 0.92). A prognostic scoring system using vascular invasion, age, and serum calcium level at initial parathyroidectomy can be used to predict RFS. This categorization might be helpful for clinical decisions relative to the timing and use of adjuvant therapy. Comprehensive validation using multiple cohorts will be needed to confirm applicability.
引用
- Silva-Figueroa AM, Hess KR, Williams MD, et al. Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg. 2017. PMID: 28427885. doi:10.1016/j.jamcollsurg.2017.01.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。